SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Chugai Pharmaceutical Co Ltd - Regarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For SMA

Chugai Pharmaceutical Co Ltd TSE:4519

4519